Figure 2From: Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South AfricaReceiver operating characteristic (ROC) curve analysis showing the utility of plasma suPAR concentration as a prognostic test predicting death up to the first 4 months of ART. The area under the curve is 0.681.Back to article page